Metraipolis › archive › dc_000ea98d99f1

Remyelination as a therapeutic target in the treatment of multiple sclerosis — Europe PMC PMID:41523329

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41523329
DOI
10.3934/neuroscience.2025027
License (as archived)
solo-consultazione
Archived
2026-11-08T18:31:32.958Z
SHA-256 of the archived text
bf7bbcd84ee298aa8af97b234b70391bbed9538a3b7af38372a3f50d46cf1160
Stable URL of this page
https://metraipolis.com/documento/dc_000ea98d99f1

How to cite

Remyelination as a therapeutic target in the treatment of multiple sclerosis — Europe PMC PMID:41523329 — Europe PMC (en), https://europepmc.org/article/MED/41523329 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_000ea98d99f1 (Metraipolis archive dc_000ea98d99f1, sha256 bf7bbcd84ee298aa8af97b234b70391bbed9538a3b7af38372a3f50d46cf1160)
BibTeX
@misc{dc000ea98d99f1,
  title = {Remyelination as a therapeutic target in the treatment of multiple sclerosis — Europe PMC PMID:41523329},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41523329},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_000ea98d99f1; sha256 bf7bbcd84ee298aa8af97b234b70391bbed9538a3b7af38372a3f50d46cf1160},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41523329. Agents can read the archived copy with the MCP tool read_document.